Skip to main content
. 2019 Dec 2;23(11):1965–1973. doi: 10.1017/S1368980019003331

Table 4.

Associations of folic acid supplementation and dietary folate intake with the risk of nulliparous small for gestational age (SGA) and multiparous SGA among women (n 8758) and their children enrolled in the 2010–2012 Gansu Provincial Maternity and Child Care Hospital birth cohort, Lanzhou, China

Folic acid/folate intake duration Nulliparous SGA Multiparous SGA
Controls
(n 5826)
Cases
(n 535)
OR 95 % CI OR* 95 % CI Controls
(n 2148)
Cases
(n 249)
OR 95 % CI OR* 95 % CI
Folic acid supplement
  Non-users 982 138 1·00 Ref. 1·00 Ref. 780 114 1·00 Ref. 1·00 Ref.
  Users 4844 397 0·58 0·48, 0·72 0·67 0·54, 0·84 1368 135 0·68 0·52, 0·88 0·80 0·61, 1·06
    ≤12 weeks 2379 224 0·67 0·54, 0·84 0·73 0·58, 0·93 860 97 0·77 0·58, 1·03 0·90 0·67, 1·22
    >12 weeks 2465 173 0·71 0·63, 0·80 0·79 0·69, 0·91 508 38 0·72 0·59, 0·87 0·77 0·63, 0·95
    P trend <0·001 <0·001 <0·001 0·022
    Per 2-week increase 0·949 0·932, 0·967 0·965 0·946, 0·985 0·933 0·902, 0·966 0·951 0·917, 0·985
  Before conception and during pregnancy 1971 132 0·48 0·37, 0·61 0·62 0·46, 0·83 373 23 0·42 0·27, 0·67 0·52 0·32, 0·85
    <24 weeks 889 64 0·51 0·35, 0·70 0·64 0·45, 0·91 212 14 0·62 0·44, 0·88 0·70 0·48, 1·01
    ≥24 weeks 1082 68 0·67 0·58, 0·78 0·79 0·66, 0·94 161 9 0·45 0·25, 0·80 0·53 0·29, 0·97
    P trend <0·001 0·002 <0·001 0·010
    Per 2-week increase 0·941 0·921, 0·962 0·960 0·937, 0·984 0·920 0·879, 0·964 0·938 0·893, 0·986
  Before conception only 224 21 0·67 0·41, 1·08 0·85 0·51, 1·41 70 7 0·68 0·31, 1·53 0·83 0·36, 1·88
  During pregnancy only 2649 244 0·66 0·53, 0·82 0·71 0·56, 0·90 925 105 0·78 0·59, 1·03 0·90 0·67, 1·21
    ≤8 weeks 983 110 0·80 0·61, 1·04 0·78 0·59, 1·03 432 54 0·86 0·61, 1·21 0·97 0·68, 1·39
    >8 weeks 1666 134 0·76 0·67, 0·86 0·83 0·72, 0·95 493 51 0·71 0·50, 1·01 0·79 0·54, 1·14
    P trend <0·001 0·002 0·051 0·265
    Per 2-week increase 0·954 0·925, 0·982 0·969 0·941, 0·998 0·943 0·902, 0·996 0·958 0·915, 1·004
Dietary folate intake (µg/d)
  Before pregnancy
    Q1 < 115·63 1399 147 1·00 Ref. 1·00 Ref. 564 85 1·00 Ref. 1·00 Ref.
    Q2 = 115·63–157·42 1523 122 0·76 0·59, 0·99 0·90 0·68, 1·18 479 35 0·49 0·32, 0·73 0·56 0·36, 0·90
    Q3 = 157·42–218·91 1450 139 0·96 0·85, 1·08 1·07 0·94, 1·23 509 67 0·94 0·79, 1·11 0·96 0·79, 1·17
    Q4 ≥ 218·91 1454 127 0·94 0·87, 1·02 1·02 0·91, 1·14 596 62 0·88 0·79, 0·99 1·02 0·87, 1·19
    P trend 0·338 0·440 0·182 0·713
    Per 10-μg increase 1·004 0·988, 1·021 1·022 1·004, 1·041 0·979 0·956, 1·003 1·001 0·973, 1·031
  During pregnancy
    Q1 < 149·47 1294 156 1·00 Ref. 1·00 Ref. 677 84 1·00 Ref. 1·00 Ref.
    Q2 = 149·47–197·56 1484 127 0·71 0·56, 0·91 0·85 0·65, 1·12 483 58 0·97 0·68, 1·38 1·08 0·73, 1·60
    Q3 = 197·56–263·21 1560 113 0·78 0·68, 0·88 0·90 0·78, 1·05 428 53 0·99 0·83, 1·20 1·18 0·95, 1·47
    Q4 ≥ 263·21 1488 139 0·92 0·85, 0·99 1·06 0·93, 1·20 560 54 0·92 0·82, 1·04 1·11 0·92, 1·34
    P trend 0·019 0·794 0·223 0·373
    Per 10-μg increase 0·992 0·975, 1·009 1·019 0·998, 1·040 0·975 0·952, 0·999 0·999 0·969, 1·030

Q, quartile; ref., reference category.

Multiplicative interaction on nulliparous SGA: OR = 0·88 (95 % CI 0·72, 1·08), P = 0·228.

Multiplicative interaction on multiparous-SGA: OR = 0·79 (95 % CI 0·56, 1·11), P = 0·174.

*

OR adjusted for maternal age, monthly income per capita, education level, smoking, employment, pre-pregnancy BMI, weight gain during pregnancy, pre-eclampsia, caesarean section, height of child’s father, history of preterm, total energy intake, dietary folate intake or folic acid supplement.